CHANNEL THERAPEUTICS CORP (CHRO) Stock Analyst Ratings
NYSEARCA:CHRO - NYSE Arca - US1711261057 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to CHRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.67. This target is 416.07% above the current price.
CHRO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CHRO.
In the previous month the buy percentage consensus was at a similar level.
CHRO was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-06-18 | Alliance Global Partners | Initiate | Buy |